SPHERA FUNDS MANAGEMENT LTD.
TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2021-08-17
Exempt reporting adviser since 2021 · other (specify)
- Private funds1 (1 hedge) · $849.7m gross assets
- Websitespherafund.com
- Form ADV · 2026-03-17SEC adviser record
- Legal entityספרה ניהול קרנות בע"מ (IL)
- Kindhedge funds
- Others nearbyTel Aviv
As an employer
- Offices in1 country
- Private fundshedge 1
Options: 8 call positions ($135.4m notional), 5 put positions ($240.8m notional) – listed below, not included above.
This report includes the holdings of 2 other managers that share the investment decisions:
- Sphera Global Healthcare GP Ltd. – reports through this filing
- Sphera Global Healthcare Management LP – reports through this filing
Shares in two reports are counted once in each security's totals.
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ASTRAZENECA PLC SPONSORED ADR | $68.7m6.24% | Added +187.2k |
| JOHNSON & JOHNSON JNJ | $66.8m6.06% | Reduced -48.3k |
| MERCK & CO INC MRK | $60.1m5.45% | Reduced -36.2k |
| XENON PHARMACEUTICALS INC XENE | $51.4m4.66% | New |
| SANOFI SNY | $44.4m4.03% | Reduced -154.5k |
| GENERAC HLDGS INC GNRC | $43.3m3.93% | Reduced -1.3k |
| ELI LILLY & CO LLY | $41.7m3.79% | Reduced -247.3k |
| ABBVIE INC ABBV | $41.2m3.74% | Reduced -233.3k |
| C4 THERAPEUTICS INC CCCC | $19.6m1.78% | Added +21.5k |
| NICE LTD NICE | $19.0m1.72% | Added +37.3k |
| ESSA PHARMA INC EPI | $18.5m1.68% | Added +179.1k |
| KORNIT DIGITAL LTD KRNT | $18.4m1.67% | Reduced -588 |
| MICROSOFT CORP MSFT | $18.3m1.66% | Unchanged |
| KURA ONCOLOGY INC KURA | $18.1m1.64% | Added +151.1k |
| ZAI LAB LTD ZLAB | $17.3m1.57% | Added +32.2k |
| SPRINGWORKS THERAPEUTICS INC SWTX | $16.1m1.46% | Added +57.4k |
| FATE THERAPEUTICS INC FATE | $14.3m1.30% | Added +55.5k |
| LIVEPERSON INC COM | $14.2m1.29% | Reduced -35.0k |
| AMAZON COM INC AMZN | $14.0m1.27% | Added +1.3k |
| PROTAGONIST THERAPEUTICS INC PTGX | $13.6m1.23% | Added +100.8k |
| VISTAGEN THERAPEUTICS INC VTGN | $12.9m1.17% | Reduced -96.5k |
| AUDIOCODES LTD AUDC | $12.7m1.16% | Reduced -90.4k |
| KYMERA THERAPEUTICS INC KYMR | $12.6m1.14% | Added +12.4k |
| VARONIS SYS INC VRNS | $12.6m1.14% | Added +79.3k |
| ONCORUS INC COM | $12.3m1.12% | Reduced -9.6k |
| WEREWOLF THERAPEUTICS INC HOWL | $12.0m1.09% | New |
| CRINETICS PHARMACEUTICALS IN CRNX | $12.0m1.08% | Added +349.9k |
| AFFIMED N V COM | $10.9m0.98% | Added +257.7k |
| ALX ONCOLOGY HLDGS INC ALXO | $10.5m0.96% | Added +62.4k |
| TWILIO INC TWLO | $10.4m0.95% | New |
| THERAPEUTICS ACQUISITION COR COM CL A | $10.4m0.94% | Added +289.5k |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $9.9m0.89% | New |
| CAESARSTONE LTD CSTE | $9.5m0.86% | Added +109.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $9.4m0.85% | Reduced -90.9k |
| META PLATFORMS INC META | $9.4m0.85% | New |
| SOLAREDGE TECHNOLOGIES INC SEDG | $8.9m0.81% | New |
| INTELLIA THERAPEUTICS INC NTLA | $8.5m0.77% | New |
| BIOGEN INC BIIB | $8.3m0.75% | Added +17.2k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $8.2m0.75% | Unchanged |
| NAUTILUS BIOTECHNOLOGY INC NAUT | $8.1m0.73% | New |
| NKARTA INC NKTX | $8.0m0.73% | Added +151.5k |
| SHATTUCK LABS INC STTK | $7.9m0.72% | Added +133.5k |
| ONTO INNOVATION INC ONTO | $7.9m0.71% | Reduced -17.5k |
| STOKE THERAPEUTICS INC STOK | $7.8m0.71% | Added +82.4k |
| DYNE THERAPEUTICS INC DYN | $7.8m0.71% | Reduced -80.3k |
| MIRATI THERAPEUTICS INC MRTX | $7.6m0.69% | Added +17.5k |
| BCLS ACQUISITION CORP COM CL A | $7.2m0.66% | Unchanged |
| BEIGENE LTD ONC | $7.2m0.65% | Unchanged |
| IDEAYA BIOSCIENCES INC IDYA | $7.0m0.64% | Added +132.8k |
| VERINT SYS INC VRNT | $6.8m0.61% | New |
| ALTIMMUNE INC ALT | $6.7m0.61% | New |
| NURIX THERAPEUTICS INC NRIX | $6.5m0.59% | Added +29.1k |
| MERUS N V MRUS | $6.0m0.55% | Added +209.5k |
| RESEARCH ALLIANCE CORP II COM CL A | $6.0m0.54% | Unchanged |
| ORCHARD THERAPEUTICS PLC ORTX | $6.0m0.54% | Unchanged |
| ATERIAN INC ATER | $5.9m0.53% | New |
| SUTRO BIOPHARMA INC COM | $5.5m0.50% | Unchanged |
| ALLOT LTD ALLT | $5.5m0.50% | Reduced -144.0k |
| ARS PHARMACEUTICALS INC SPRY | $5.4m0.49% | Added +6.1k |
| ARYA SCIENCES ACQU CORP IV CL A | $5.4m0.49% | Unchanged |
| UNIQURE NV QURE | $5.3m0.48% | New |
| VERONA PHARMA PLC VRNA | $5.2m0.48% | Unchanged |
| FIVERR INTL LTD FVRR | $5.2m0.47% | New |
| INHIBRX INC INBX | $5.2m0.47% | Added +74.4k |
| CURIS INC COM NEW | $4.7m0.43% | Reduced -297.6k |
| CVRX INC CVRX | $4.2m0.38% | New |
| SUNRUN INC RUN | $4.0m0.36% | New |
| I MAB NBP | $3.9m0.35% | Reduced -8.6k |
| SIGILON THERAPEUTICS INC COM | $3.9m0.35% | Reduced -2.0k |
| BEAM THERAPEUTICS INC BEAM | $3.7m0.33% | New |
| PLAYTIKA HLDG CORP PLTK | $3.6m0.32% | New |
| ARKO CORP ARKO | $3.4m0.31% | Reduced -38.1k |
| ANNEXON INC ANNX | $3.3m0.30% | New |
| EUCRATES BIOMEDICAL ACQU COR SHS | $3.2m0.29% | Added +25.0k |
| IVERIC BIO INC OPHT | $3.2m0.29% | New |
| REPARE THERAPEUTICS INC RPTX | $3.1m0.28% | Reduced -147.7k |
| GRACELL BIOTECHNOLOGIES INC SPONSORED ADS | $3.0m0.28% | Added +21.2k |
| CYCLACEL PHARMACEUTICALS INC COM | $3.0m0.27% | Unchanged |
| TREMOR INTL LTD ADS | $3.0m0.27% | New |
| VINCERX PHARMA INC COM NEW | $3.0m0.27% | Added +133.7k |
| SENTINELONE INC S | $2.9m0.26% | New |
| PMV PHARMACEUTICALS INC PMVP | $2.9m0.26% | Added +40.7k |
| ACHILLES THERAPEUTICS PLC SPONSORED ADS | $2.9m0.26% | Reduced -7.8k |
| ARGENX SE ARGX | $2.8m0.25% | Unchanged |
| FREQUENCY THERAPEUTICS INC COM | $2.7m0.25% | New |
| CYTEIR THERAPEUTICS INC COM | $2.7m0.24% | New |
| PERRIGO CO PLC PRGO | $2.4m0.22% | New |
| TWIST BIOSCIENCE CORP TWST | $2.4m0.22% | New |
| CEREVEL THERAPEUTICS HLDNG I *W EXP 06/09/202 | $2.4m0.22% | Reduced -1.0k |
| CENTURY THERAPEUTICS INC IPSC | $2.3m0.21% | New |
| LAVA THERAPEUTICS NV LVTX | $2.3m0.21% | Added +1.5k |
| MONTE ROSA THERAPEUTICS INC GLUE | $2.3m0.21% | New |
| TURMERIC ACQUISITION CORP CL A | $2.2m0.20% | Unchanged |
| JIYA ACQUISITION CORP COM CL A | $2.0m0.18% | Unchanged |
| HEALTHCOR CATALIO ACQU CORP HYPR | $2.0m0.18% | Unchanged |
| HEALTHCARE CAPITAL CORP UNIT 12/31/2025 | $2.0m0.18% | Reduced -203.4k |
| ALDEYRA THERAPEUTICS INC ALDX | $1.7m0.15% | New |
| WIX COM LTD WIX | $1.7m0.15% | Unchanged |
| PLIANT THERAPEUTICS INC PLRX | $1.5m0.13% | New |
| SINGULAR GENOMICS SYSTEMS IN COM | $1.5m0.13% | New |
Sold out since Q1 2021
| Security | Value then |
|---|---|
| BRISTOL-MYERS SQUIBB CO BMY | $12.6m200.0k shares |
| PALO ALTO NETWORKS INC PANW | $10.4m32.3k shares |
| BOLT BIOTHERAPEUTICS INC | $7.9m241.0k shares |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $7.6m175.1k shares |
| MOHAWK GROUP HLDGS INC | $7.4m251.0k shares |
| TRILLIUM THERAPEUTICS INC TR | $7.2m670.5k shares |
| CYBERARK SOFTWARE LTD CYBR | $7.1m55.0k shares |
| COGENT BIOSCIENCES INC COGT | $6.7m762.6k shares |
| KALVISTA PHARMACEUTICALS INC KALV | $6.7m258.9k shares |
| IONIS PHARMACEUTICALS INC IONS | $6.5m145.5k shares |
| ARYA SCIENCES ACQUISITION CO NAUT | $5.5m400.0k shares |
| BAIDU INC BIDU | $5.4m25.0k shares |
| RADA ELECTR INDS LTD RADA | $4.9m407.9k shares |
| REINVENT TECHNOLOGY PARTNERS | $4.7m468.0k shares |
| CELLDEX THERAPEUTICS INC NEW CLDX | $4.5m220.3k shares |
| MEREO BIOPHARMA GROUP PLC MREO | $4.4m1.3m shares |
| FARFETCH LTD FTCHQ | $4.2m80.0k shares |
| ORIC PHARMACEUTICALS INC ORIC | $4.2m169.9k shares |
| FORESIGHT ACQUISITION CORP | $4.2m420.0k shares |
| INFLARX NV IFRX | $3.9m1.0m shares |
| CATABASIS PHARMACEUTICALS IN CATB | $3.7m1.3m shares |
| EDGEWISE THERAPEUTICS INC EWTX | $3.2m100.0k shares |
| LONGVIEW ACQUISITION CORP II | $3.0m300.0k shares |
| GALERA THERAPEUTICS INC | $2.9m323.3k shares |
| GALECTO INC GLTO | $2.7m448.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $84.6m625.0k shares | New |
| MERCK & CO INC MRK · Put | $60.1m772.6k shares | New |
| ENPHASE ENERGY INC ENPH · Call | $42.2m230.0k shares | Unchanged |
| ISHARES TR IGV · Put | $41.0m105.0k shares | Added |
| SELECT SECTOR SPDR TR XLK · Put | $31.0m210.0k shares | New |
| ISHARES TR IWM · Put | $24.1m105.0k shares | Reduced |
| FIVERR INTL LTD FVRR · Call | $19.2m79.0k shares | Reduced |
| TEVA PHARMACEUTICAL INDS LTD Call | $18.9m1.9m shares | Added |
| INVESCO EXCH TRADED FD TR II TAN · Call | $18.8m210.0k shares | New |
| BIOGEN INC BIIB · Call | $17.3m50.0k shares | New |
| IONIS PHARMACEUTICALS INC IONS · Call | $7.4m186.6k shares | New |
| AGIOS PHARMACEUTICALS INC AGIO · Call | $6.4m116.0k shares | New |
| ATERIAN INC ATER · Call | $5.2m355.6k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 | 7.8% |
| TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 | 7.1%≈ $38.8m |
Trades reported as a company insider in Q2 2021
Owning 10% or more of a company, or having someone on its board, makes this manager an insider there: it reports its trades in that company's shares on Form 4 within two business days. Open-market and private purchases and sales only.
| Date | Company | Trade | Value |
|---|---|---|---|
| 2021-05-04 | WEREWOLF THERAPEUTICS INC 10% owner · See footnote | Bought | $7.6m475.0k shares |